Skip to main content

Table 3 Unobserved induction outcomes

From: Public sector low threshold office-based buprenorphine treatment: outcomes at year 7

Induction outcome n (%)
Unobserved induction cases 305 (100)
Lost to follow-up at week 1 52 (17)
≥1 induction-related adverse event (AE) 38 (13)
 Precipitated withdrawal 10 (3)
 Prolonged withdrawal 13 (4)
 Serious adverse event (SAE) 0 (0)
 Other induction-related AEa 15 (5)
  1. aOther reported AEs included likely induction-related complaints not consistent with precipitated or prolonged withdrawal syndromes